Incidence and Risk Factors for #Hypertension among Children with #Nephrotic Syndrome ⁦@JPediatr⁩ #HTN #Nephrotic

Central venous catheter–related bloodstream infections (CRBSI) are common in children receiving hemodialysis & cause significant morbidity & healthcare costs. Read this Original Article on use of 4% tetrasodium EDTA (KiteLock™) to prevent CRBSI. https://t.co/67IF3Zsh3l

Steroid-sparing immunosuppression is used in 50% of children w/nephrotic syndrome, but rates & predictors of prolonged remission after cyclophosphamide & tacrolimus are uncertain. Read this Original Article for more. https://t.co/awBN89O0zU

I have made the jump over to BlueSky - follow me there at the same handle @KidneyCal https://t.co/0kHQ68F1QD

AKI affects a growing number of children and neonates and is associated with high morbidity, mortality, and health care expenditure. In this issue of JASN, Robinson et al. present the findings of a large cohort study on the long-term outcomes of AKI in hospitalized children who

How can simulation be used to improve the design adaptive clinical trials? Read our review article just published in @JASN_News to find out! Big thanks to co-authors @DrRulanParekh @douyang3 @efan75 @BrianCuthberts8 and Anna Heath. https://t.co/N4fEpJ9vJH

Long-Term Kidney Outcomes after Pediatric AKI ca. 2024 from @JASN_News #Nephpearls #KidneyWk #BestofJASN #VisualAbstract by @nikkonephro 👉 https://t.co/cGNGutIOOA

Article link:

Great to see our pediatric AKI long-term outcomes study highlighted in the Best of ASN Journals session at #ASNKids24 #ASN24 @ChanchlaniRahul

Amazing to see a childhood nephrotic syndrome RCT in the #ASNKids24 ⁦@ASNKidney⁩ late breaking trials session! So exciting to see RCTs starting to emerge to improve treatment for these children

Excellent poster by Cal Robinson et al on a target trial emulation of cyclophosphamide vs CNIs in #nephroticsyndrome ! #ASNKids24 @ASPNeph @ASNKidney

https://t.co/uGkCgdmplP

Come visit our posters today at #ASN2024 #ASNKIDS24 @ASNKidney. PO-720: Comparative Effectiveness of Cyclophosphamide and Calcineurin Inhibitors in Childhood Nephrotic Syndrome PO-386: Health Care Resource Utilization and Costs Associated with Childhood Hypertension

Using population-based health administrative databases, study investigators found that 1/3 of children with posterior urethral valves develop major adverse kidney events (death, kidney failure, or CKD) by early adulthood, compared with 1% of the general childhood population.

Long-Term Kidney Outcomes in Children with Posterior Urethral Valves #PUV @JASN_News https://t.co/am5kGQBX55

Children with posterior urethral valves are at long-term risk of CKD, kidney failure, and hypertension. One-third develop major adverse kidney events over median 16.6 year follow-up. Kidney health surveillance into adulthood with improved transition planning is needed!

Long-Term Kidney Outcomes after Pediatric Acute Kidney Injury #AKI https://t.co/ggqo1VOn52 @JASN_News

Meet IMPaCT Fellow @KidneyCal ! Through his research, Cal aspires to advance the evidence-based treatment of pediatric kidney diseases, prevent adverse long-term outcomes, and minimize disease burden. Learn more about Cal’s project here: https://t.co/jFeuOHImj1

Interested in learning how to design and operate clinical trials for pregnant people and kids? 🤰👶🧒 Apply for an IMPaCT training award at https://t.co/XzwhwAMhgF! Applications are open now, so don't miss out – submit by 5 PM CT on October 18, 2024!

Using population health databases from Ontario, Canada, investigators found that children surviving AKI without acute KRT were at higher long-term risk of CKD, long-term KRT, hypertension, and subsequent AKI compared with hospitalized children without AKI https://t.co/GyvRh3ZhhW